E-LIB Suche - Ergebnisse für: Worden, F.

1

A Phase 1 Dose-escalation and Expansion Study of CUE-101, G..:

Colevas, A.D. ; Chung, C.H. ; Adkins, D....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e87 , 2024

Link: https://doi.org/10.1016/..

2

Phase II Trial Assessing Safety, Efficacy and Immune Correl..:

Gibson, M. ; Savvides, P. ; Worden, F....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e89-e90 , 2024

Link: https://doi.org/10.1016/..

3

CLIA Validation of a New High Performance HPV ctDNA Assay C..:

Hochfelder, C. ; Walline, H. ; Bhambhani, C....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e62-e63 , 2024

Link: https://doi.org/10.1016/..

4

FDG-PET-based Selective De-escalation of Radiotherapy for H..:

Regan, S.N. ; Rosen, B.S. ; Suresh, K....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e11 , 2024

Link: https://doi.org/10.1016/..

5

Phase I/II Study of A Novel MDM-2 Inhibitor (APG-115-Alrizo..:

Pearson, A. ; Muzaffar, J. ; Kirtane, K....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e6-e7 , 2024

Link: https://doi.org/10.1016/..

6

Clinical Variables Associated with Survival and Treatment R..:

Haring, C.T. ; Kana, L. ; Dermody, S....
International Journal of Radiation Oncology*Biology*Physics. 112 (2022) 5 - p. e44 , 2022

Link: https://doi.org/10.1016/..

7

Early Toxicity and Patient Reported Outcomes From a Phase 2..:

Allen, S.G. ; Rosen, B.S. ; Aryal, M.P....
International Journal of Radiation Oncology*Biology*Physics. 112 (2022) 5 - p. e3 , 2022

Link: https://doi.org/10.1016/..

8

Randomized Phase II Study of DCE-MRI-Based Dose Escalation ..:

Mierzwa, M.L. ; Lee, C. ; Schipper, M....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. S62-S63 , 2021

Link: https://doi.org/10.1016/..

9

Anticipating Poor Outcomes: A Prognostic Machine Learning M..:

Mayo, C. ; Mierzwa, M.L. ; Medlin, R....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. S64-S65 , 2021

Link: https://doi.org/10.1016/..

10

Dosimetric Analysis for Predicting Secondary Lymphedema Aft..:

Jaworski, E. ; Sun, Y. ; Vineberg, K.A....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e371 , 2021

Link: https://doi.org/10.1016/..

11

A Matched Comparison of Early Toxicity in p16+ Oropharynx C..:

Morales Rivera, K.A. ; Sun, Y. ; Gharzai, L.A....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e401 , 2021

Link: https://doi.org/10.1016/..

12

Quantitate Image Responses in High Risk p16+ Oropharyngeal ..:

Cao, Y. ; Aryal, M.P. ; Lee, C....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. S16 , 2021

Link: https://doi.org/10.1016/..

13

Local Control With Cemiplimab Monotherapy for Unresectable ..:

Jaworski, E. ; Sun, Y. ; Schonewolf, C....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e417 , 2021

Link: https://doi.org/10.1016/..

14

2-Year Outcomes Of Phase Iib, Randomized, Double-Blind Tria..:

Anderson, C.M. ; Lee, C.M. ; Saunders, D....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e789 , 2020

Link: https://doi.org/10.1016/..

15

A multi-center phase II trial evaluating the efficacy of pa..:

Swiecicki, P.L. ; Durm, G. ; Bellile, E....
International Journal of Radiation Oncology*Biology*Physics. 106 (2020) 5 - p. 1178-1179 , 2020

Link: https://doi.org/10.1016/..